![](https://www.mitacs.ca/wp-content/uploads/2023/12/generic-logo-background.png)
Schizophrenia is a debilitating psychiatric disorder characterized by positive (hallucinations, delusions), negative (lack of motivation, flat affect), and cognitive (impaired memory and attention) symptoms. Aripiprazole, a dual-action antipsychotic, shows promise in enhancing brain structure and memory in schizophrenia, which may have downstream positive effects on negative symptoms and outcome. However, the mechanisms and timing underlying […]
Read More